Please grant Warrior “compassionate use” and allow her to take (Radium 223) Xofigo for her Metastatic Breast Cancer. She has tried the chemo drugs that are available to her and undergone extensive radiation, but they have not stopped the cancer from progressing throughout her body.
Why is this important?
My friend Warrior, a mother of two young children, is fighting Metastatic Breast Cancer as I am, and she’s almost run out of options. But a drug Bayer makes called Xofigo (Radium 223) could save her life. Please, ask Bayer to grant Warrior “compassionate use” and allow her to take Xofigo.
Warrior was first diagnosed with breast cancer in 2001. She has tried the chemo drugs that are available to her and undergone extensive radiation, but they have not stopped the cancer from progressing throughout her body. She has even broken her sacrum and been wheelchair bound in an attempt to stop the cancer.
But there is one drug Warrior’s oncologist believes provides significant promise to her – Radium 223. It’s made under the brand name Xofigo by Bayer, and has been successful in treating prostate cancer that has metastasized to the bone. The drug was approved in July by the FDA, but Warrior can’t access it because it was approved to treat prostate cancer, not breast cancer.
This young mother has been fighting cancer for over a decade, and this drug is her last chance. Please, ask Bayer to do the right thing and grant Warrior compassionate use of Xofigo.
